Skip to content

Health

Adding years to life and life to years

Source: Mckinsey

Despite dramatic advancements in prolonging and improving life over the past century (with average life expectancy climbing from 54 years in 1960 to 73 years at latest estimates)—ranging from reduced infant mortality rates to the unprecedented speed and scale of COVID-19-vaccine development—consider that the share of lives spent in poor health has not substantially diminished…

Read More

When Will We Have A Pill To Treat Covid? Here Are Three Antiviral Drugs Being Tested

Source: Forbes

 Merck said molnupiravir, the antiviral drug it’s developing with Miami-based Ridgeback Biotherapeutics, could halve the risks of hospitalization or death when given to recently diagnosed patients at risk of severe illness, according to interim results from a late-stage clinical trial. If approved, molnupiravir would be the first antiviral pill for Covid-19 on the market and…

Read More

Fulfilling the promise of advanced analytics in oncology

Source: Mckinsey

In oncology we have read the exciting headlines predicting that big data and advanced analytics will transform cancer care and research and that all patients, thanks to machine learning, will soon receive personalized treatment plans. But progress has been arguably slower than initially envisioned. However, without a doubt, important advances are being made. Researchers have…

Read More

Pupil Size Is a Marker of Intelligence

Source: Scientific American

Our pupils respond to more than just the light. They indicate arousal, interest or mental exhaustion. Pupil dilation is even used by the FBI to detect deception. Now work conducted in our laboratory at the Georgia Institute of Technology suggests that baseline pupil size is closely related to individual differences in intelligence. The larger the pupils, the…

Read More
Scroll To Top